tiprankstipranks
Advertisement
Advertisement
Callio Therapeutics Highlights Progress of Dual-Payload ADC CLIO-8221 in Phase 1 Trial
PremiumPrivate CompaniesCallio Therapeutics Highlights Progress of Dual-Payload ADC CLIO-8221 in Phase 1 Trial
24d ago
Callio Therapeutics Highlights Dual-Payload ADC Platform and Phase 1 HER2 Program
Premium
Private Companies
Callio Therapeutics Highlights Dual-Payload ADC Platform and Phase 1 HER2 Program
25d ago
Callio Therapeutics Highlights Progress in Dual-Payload ADC Oncology Pipeline
Premium
Private Companies
Callio Therapeutics Highlights Progress in Dual-Payload ADC Oncology Pipeline
26d ago
Callio Therapeutics Highlights Clinical-Stage Dual-Payload ADC Program
PremiumPrivate CompaniesCallio Therapeutics Highlights Clinical-Stage Dual-Payload ADC Program
1M ago
Callio Therapeutics Highlights Dual-Payload ADC Program and CLIO-8221 at AACR 2026
Premium
Private Companies
Callio Therapeutics Highlights Dual-Payload ADC Program and CLIO-8221 at AACR 2026
1M ago
Callio Therapeutics Highlights Progress on CLIO-8221 and Dual-Payload ADC Pipeline
Premium
Private Companies
Callio Therapeutics Highlights Progress on CLIO-8221 and Dual-Payload ADC Pipeline
1M ago
Callio Therapeutics Doses First Patient in Global Phase I Trial of Dual-Payload HER2 ADC CLIO-8221
PremiumPrivate CompaniesCallio Therapeutics Doses First Patient in Global Phase I Trial of Dual-Payload HER2 ADC CLIO-8221
2M ago
Callio Therapeutics Advances First Dual-Payload ADC Into Phase I Trial
Premium
Private Companies
Callio Therapeutics Advances First Dual-Payload ADC Into Phase I Trial
2M ago
Callio Therapeutics Highlights Dual-Payload ADC Strategy in Oncology
Premium
Private Companies
Callio Therapeutics Highlights Dual-Payload ADC Strategy in Oncology
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100